Key Points
- Acquisition finalized: KT&G and Altria to acquire Another Snus Factory (“LOOP”) for approx. USD 197 million, with KT&G holding 51% and Altria 49%.
- Market momentum: Global nicotine pouch volumes grew 36.9% YoY in 2024; the U.S. accounts for ~65% of demand. Pouches expected to reach 10–15% of U.S. nicotine consumption by 2029.
- Regulatory tailwind: Twenty pouch products have U.S. FDA authorization; pilot fast-track PMTA review has launched, providing greater regulatory clarity.
- E-vapor challenges: KT&G’s vaping rollout, including the “myon” device, has seen limited scale amid tightening regulation and intensified competition, offering less short-term visibility than pouches.
- Alliance strategy: After partnering with PMI to globalize its lil HNB platform, KT&G again adopts a “coalition entry” model, leveraging Altria’s U.S. route-to-market and regulatory execution.
2Firsts | November 5, 2025 — Korea Tobacco & Ginseng Corp. (KT&G) is accelerating its smokeless portfolio expansion, with nicotine pouches emerging as its latest strategic focus.
On Oct. 30, Altria highlighted ongoing collaboration with KT&G in “modern oral nicotine” during its Q3 earnings call, reinforcing the strategic MOU signed in September. The move signals a shift from framework cooperation to execution.
Strategic Inflection: Entry via Acquisition
Under the agreement, KT&G and Altria will jointly acquire 100% of Another Snus Factory (ASF) for KRW 262 billion (~USD 197 million), with KT&G holding 51% and Altria 49%.
The transaction marks KT&G’s formal entry into nicotine pouches. Rather than building an ecosystem from scratch, KT&G gains immediate access to mature product lines, manufacturing assets, and local R&D capabilities.
ASF’s flagship brand LOOP, launched in 2019, has built consumer traction in Sweden and other Nordic markets, often viewed as a symbol of local innovation.
Market data reviewed by 2Firsts shows LOOP recently adjusted retail pricing downward by 10–50% in Sweden, with pack prices shifting from USD 4.99 to USD 2.50–4.49. ZYN remains priced at ~USD 4.99.
Why Nicotine Pouches? Market + Regulatory Window
Pouches are transitioning from a niche substitute to a mainstream nicotine format.
According to the 2024 World Tobacco Development Report, global pouch volumes rose 36.9% YoY to 21.23B in 2024, with revenue surging 51% to USD 11.25B, led by the U.S. (~83%).
Euromonitor projects pouches will represent 10–15% of U.S. nicotine consumption by 2029.
Regulation is maturing. GINN analysis submitted to 2Firsts shows 57 countries adopting four broad regulatory models, with outright bans a minority and structured governance expanding.
In the U.S., 20 pouch SKUs have received FDA authorization, and fast-track PMTA evaluation has launched. In contrast, e-vapor faces heavy PMTA pressure and tighter EU disposable rules.
Regulatory certainty is reshaping capital allocation across tobacco majors.
E-Vapor: Slower Traction for KT&G
Unlike its decisive move in pouches, KT&G’s progress in vaping has been slower. Product refresh cadence and geographic rollout have lagged peers such as PMI and BAT.
At InterTabac 2024, 2Firsts captured the debut of KT&G’s disposable brand myon, then positioned for Mongolia before seeking global distribution. Public updates since then remain sparse, and the product has yet to scale across core markets.
Rising global competition, tighter regulations, and high channel barriers have constrained e-vapor as a near-term growth engine.
Faced with reduced certainty in e-vapor and policy headwinds, KT&G is channeling investment into nicotine pouches as a structurally clearer pathway.
Why Altria? KT&G’s Alliance Doctrine
KT&G’s partnership with Altria reflects a consistent “alliance-driven globalization” model.
Previous example: cooperation with PMI enabled lil HNB devices to enter 30+ markets.
Rather than executing a fully independent global rollout, KT&G has favored leveraging established partners to accelerate market penetration, regulatory interface, and execution capacity.
The nicotine pouch category is entering a consolidation phase led by ZYN, with VELO and on! expanding aggressively. The ASF acquisition secures KT&G’s product and manufacturing base, while Altria provides access to the U.S.—the category’s largest and most regulated market.
With Altria’s PMTA track record and retailer network, KT&G gains higher entry certainty and faster commercial validation potential.
This is not merely an expansion into a new segment; it reflects KT&G’s strategic philosophy:do not go alone in a high-barrier market. Partner to win scale and regulatory certainty.
As global next-gen nicotine competition intensifies, KT&G’s alliance-first strategy may emerge as a distinctive competitive model versus fully in-house expansion paths taken by other multinationals.
